# Neuroprotection in Patients Undergoing Aortic Valve Replacement

Study · id `cardio:ct-nct02389894` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02389894](<https://clinicaltrials.gov/study/NCT02389894>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02389894

Browse, organ or system: Heart; Brain  
Browse, condition area: Stroke; Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 383 participants.

## Technical summary

Registry record NCT02389894. Randomized; single masking; primary purpose prevention. Start 2015-03 (registry gives no type); primary completion 2017-01 (actual). Results posted on 2019-04-29.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 383 participants (enrolled count; ClinicalTrials.gov record NCT02389894, source copy `cardio:ctgov-nct02389894-2019-04-29`, retrieved 2026-10-26)
- Start date: 2015-03 (registry gives no type) (ClinicalTrials.gov record NCT02389894, source copy `cardio:ctgov-nct02389894-2019-04-29`, retrieved 2026-10-26)
- Primary completion: 2017-01 (actual) (ClinicalTrials.gov record NCT02389894, source copy `cardio:ctgov-nct02389894-2019-04-29`, retrieved 2026-10-26)
- Completion: 2017-01 (actual) (ClinicalTrials.gov record NCT02389894, source copy `cardio:ctgov-nct02389894-2019-04-29`, retrieved 2026-10-26)
- Results first posted: 2019-04-29 (ClinicalTrials.gov record NCT02389894, source copy `cardio:ctgov-nct02389894-2019-04-29`, retrieved 2026-10-26)
- Countries: United States; Canada (ClinicalTrials.gov record NCT02389894, source copy `cardio:ctgov-nct02389894-2019-04-29`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02389894-2019-04-29`, retrieved 2026-10-26)

## The registry's words

- Brief title: Neuroprotection in Patients Undergoing Aortic Valve Replacement
- Condition: Aortic Stenosis
- Condition: Brain Infarction
- Condition: Cerebrovascular Accident
- Condition: Stroke
- Intervention (Device): Embol-X Embolic Protection Device
- Intervention (Device): CardioGard Cannula
- Lead sponsor: Icahn School of Medicine at Mount Sinai
- Lead sponsor class: OTHER
- Collaborator: National Heart, Lung, and Blood Institute (NHLBI)
- Collaborator class: NIH

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Icahn School of Medicine at Mount Sinai (`cardio:org-icahn-school-of-medicine-at-mount-sinai`)
- Registry lists this organization as a collaborator: National Heart, Lung, and Blood Institute (`cardio:nhlbi`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of Cerebral Embolic Protection Devices on CNS Infarction in Surgical Aortic Valve Replacement: A Randomized Clinical Trial (`cardio:pubmed-28787505`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: The impact of perioperative stroke and delirium on outcomes after surgical aortic valve replacement (`cardio:pubmed-35483981`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 3b1c558fa4ba553569f0b47f6f4f5f576fb24f6b4379a3ffaac167d5d7638aa4
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
